B-Cell Depletion Improves Islet Allograft Survival with Anti-CD45RB

Kang Mi Lee, Heidi Yeh, Gaoping Zhao, Lingling Wei, Matthew R. O’Connor, Ryan Stott, Julie Soohoo, K. Dunussi, Paolo Fiorina, Shaoping Deng,

Cell Transplantation · 2012 · 16 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

A short course of anti-CD45RB leads to long-term islet allograft survival and donor-specific tolerance in approximately half of immunocompetent mice. We have previously demonstrated that anti-CD45RB antibody-mediated tolerance requires B-cells for cardiac allograft survival. We therefore asked whether B-cells were also required for anti-CD45RB antibody-mediated survival of islets. Unexpectedly, we found that nearly 100% of islet allografts survive long term in B-cell-deficient mice. Similarly, B-cell depletion by anti-CD22/cal augmented anti-CD45RB-mediated tolerance when administered pretransplant, although it had no effect on tolerance induction when administered posttransplant. Our results demonstrate that the role of B-cells in promoting tolerance with anti-CD45RB is graft specific, promoting tolerance in cardiac grafts but resisting tolerance in islet transplantation. These findings may help elucidate the varied action of B-cells in promoting tolerance versus rejection.

References

30